The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Thu., Feb. 27, 3:44 PM

Slide #12. Hollister Biosciences Inc. Venom Extracts

Acquirer: Hollister Biosciences Inc. (HSTRF)
Acquiree: Venom Extracts
Details: Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") - a vertically integrated cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company signed a Letter of Intent ("LOI") on February 20th, 2020 to acquire Venom Extracts ( "Venom"), one of Arizona's premier extract brands and one of the state's largest producers of award-winning medical cannabis distillate and related products.

Hastings Resource is in the process of identifying, evaluating and negotiating business opportunities in the resource industry.

Open the HSTRF Page at The Online Investor »

Company Name: 
Trigen Resources Inc
Precious Metals

Open the HSTRF Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.